MED55 - Influenza Vaccine

The Commonwealth of Massachusetts is announcing a cooperative contract through the MMCAP Infuse Group Purchasing Organization for the procurement of influenza vaccines under contract MED55. This contract will become effective after the current MED54 Influenza Vaccine contract expires on January 31, 2022. The MMCAP Infuse RFP for Distribution of Vaccines Including Influenza was released by the State of Minnesota on June 3, 2019 and closed on July 23, 2019. MMCAP's contracts for Influenza Vaccine with Manufacturers were negotiated through a Single Source Acquisition. Participation in MMCAP is limited to facilities within member states that are specifically permitted by the member state's statutes to purchase goods from the member state's contracts, which generally includes facilities run by state agencies, counties, cities, townships, and school districts.

This is not a Commonwealth bid or COMMBUYS solicitation, and all questions about the MMCAP Infuse solicitation and awarded contracts must be addressed to the contact listed in the downloadable contract/bid documents. There are no set-aside designations or restrictions on the types of organizations that can respond, and no information is provided about incumbent vendors, current contractors, existing infrastructure, or technology integration requirements. Additionally, no award values or budget ranges are specified.